Search for: "C Lillie" Results 321 - 340 of 444
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
13 Feb 2014, 4:56 am by Joy Waltemath
Summary judgment was thus denied in part (Johnson v Federal Express Corporation, February 10, 2014, Conner, C). [read post]
2 Nov 2007, 11:00 pm
.: (Poland-IP law),The Biological Diversity Act: (SpicyIP),IP and Traditional Medicine: (SpicyIP), Internationalised Domain Names and India: (SpicyIP),Organization of Pharmaceutical Producers of India, (OPPI) which represents foreign-owned drug firms reiteratee its demand for removal of the pre-grant opposition provision from the Indian patent law (citing misuse by generic companies): (livemint), Lilly inked a deal with India-based Glenmark Pharmaceuticals to acquire rights to a portfolio… [read post]
9 May 2007, 1:34 pm
That test changes the nature of Rule 23(c)(4) dramatically, by making it potentially applicable to any "common issue" no matter how many other individual issues remain.The Draft would thus turn the prevailing view of Rule 23(c)(4) on its head. [read post]
3 Apr 2009, 1:05 am
The appellate court upheld the Texas federal district court ruling that granted summary judgment to Eli Lilly on the grounds that the plaintiff's doctor informed him of the risks of taking Zyprexa. [read post]
13 Apr 2010, 10:26 am
Eli Lilly & Co., No. 2008-1248, 2010 WL 1007369 (Fed. [read post]
1 Dec 2017, 11:35 am by Nate Nead
Big pharma players such as Eli Lilly, Novo Nordisk and Allergan are committed to voluntary price restraints, while companies such as Novartis and Roche are in favor of value-based pricing. [read post]
24 Aug 2009, 7:01 am
(Tangible IP) Global IP law: Two recent publications ‘Global Challenge of Intellectual Property Rights’ by R Bird and S C Jain and ‘Global Intellectual Property Law’ by G Dutfield and U Suthersanen (IPKat)   Global - Trade Marks / Brands What price brands on the balance sheet? [read post]
9 Jun 2011, 10:02 am by Bexis
Eli Lilly & Co., 2009 WL 5216930, at *12 (E.D.N.Y. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]